SEC FORM 4

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roman DBDR Tech Sponsor LLC

(Last)

(First)

(Middle)

2877 PARADISE ROAD #702

(Street)

LAS VEGAS

89109

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CompoSecure, Inc. [ CMPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/27/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	12/27/2021		M⁽¹⁾		5,789,000	A	$0.00	5,789,000	D⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹⁾	12/27/2021		M			5,789,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	5,789,000	⁽¹⁾	0	D⁽²⁾
Warrants	$11.5	12/27/2021		A⁽³⁾		10,837,400		01/26/2022	12/27/2026	Class A Common Stock	10,837,400	⁽³⁾	10,837,400	D⁽⁴⁾

Explanation of Responses:

1. On December 27, 2021, Roman DBDR Tech Acquisition Corp. closed the previously announced business combination with CompoSecure Holdings, L.L.C. (the "Business Combination") pursuant to which CompoSecure, Inc. became a publicly-traded company (the "Company"). As a result of the Business Combination, each outstanding share of Class B Common Stock converted automatically on a one-for-one basis into shares of Class A Common Stock.

2. Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the shares of Class A common stock held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

3. Pursuant to the terms of the Company's warrants to purchase shares of Class A Common Stock, upon completion of the Business Combination, the warrants became exercisable beginning 30 days thereafter.

4. Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the warrants held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the warrants other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

	/s/ Dr. Donald G. Basile, as Authorized Signatory	12/29/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 4: Roman Dbdr Tech Sponsor Llc converted options into 5,789,000 shares